No Data
No Data
Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $4.9
Public Companies Invested in ICL Group Ltd (NYSE:ICL) Copped the Brunt of Last Week's US$323m Market Cap Decline
The Return Trends At ICL Group (NYSE:ICL) Look Promising
ICL Group Updates Executive Compensation Policy
ICL Announced It Has Signed A MoU With Orbia Advance Corp., S.A.B. De C.V. Fluor & Energy Materials, As Both Companies Continue To Expand Their Presence In The North American Battery Materials Supply Chain
Express News | SeaStar Medical Reports Strong Enrollment Progress In Pivotal Adult AKI Trial With 46 Total Subjects Enrolled; Trial Evaluates Safety And Efficacy Of Selective Cytopheretic Device For Acute Kidney Injury Patients In ICU